维拉佐对血清素转运体双重结合模式的结构基础
Iris E Kalenderoglou1, Andreas Nygaard1, Caleb D Vogt2
1Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Research square
|February 20, 2025
概括
胺转运体 (SERT) 是抗抑郁药的目标. 这项研究揭示了维拉佐是如何与SERT结合的,确定其内醇环对于高亲和度和独特的结合特性至关重要.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 血清载体 (SERT) 调节血清信号传递,是精神疾病治疗的主要点.
- SERT的主要结合部位 (S1) 适应胺 (5-HT) 和一些抗抑郁药物.
- 维拉佐是一种抗抑郁药,通过全结合来抑制SERT.
研究的目的:
- 为了阐明与维拉佐结合的SERT的冷-EM结构.
- 为了确定vilazodone对SERT的高度亲和力的分子决定因素.
- 描述维拉佐与SERT的独特结合机制.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定SERT结构.
- 维拉佐的分子剖析以确定关键的结合碎片.
- 生物化学试验用于测量SERT中维拉佐的解离常数 (K_D).
- 使用Anap进行特定地点的光标签,以探测形状变化.
主要成果:
- 低温-EM结构显示,维拉佐与S1位点结合,并延伸到一个全位点.
- 维拉佐的终端内醇环对于其与SERT的高亲和度结合至关重要.
- 维拉佐与其他SERT抑制剂不同,与SERT结合具有纳米分子亲和力,独立于Na+存在.
- 在使用光标记时观察到vilazodone结合后SERT的形态变化.
结论:
- 这项研究为维拉佐与SERT的独特结合方式提供了新的分子见解.
- 这些发现解释了维拉佐作为多模式抗抑郁药的独特药理特征.
- 了解这种相互作用可能有助于开发新的精神病药物.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
181
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
181
Drugs Affecting Neurotransmitter Release or Uptake
926
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
926
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
204
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
204
Antipsychotic Drugs: Typical and Atypical Agents
149
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
149
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
71
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
71


